 Following the acquisition of Bayer Animal Health, Elanco Animal Health Incorporated NYSE: ELAN has agreed to sell its sites in Shawnee, Kansas, and Speke, the U.K., to TriRx Pharmaceuticals, a Connecticut-based contract manufacturer with approximately 600 employees. The financial terms of the deal were not disclosed. 